IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders made a handsome sum after selling stock worth US$508 per share at present for US$510
Despite the fact that IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock rose 5.1% last week, insiders who sold US$127k worth of stock in the previous 12 months are likely to be better off. Selling at an average price of US$510, which is higher than the current price, may have been the wisest decision for these insiders as their investment would have been worth less now than when they sold.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for IDEXX Laboratories
The Last 12 Months Of Insider Transactions At IDEXX Laboratories
The Non-Employee Director, Jonathan Ayers, made the biggest insider sale in the last 12 months. That single transaction was for US$127k worth of shares at a price of US$510 each. So we know that an insider sold shares at around the present share price of US$508. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive). The only individual insider seller over the last year was Jonathan Ayers.
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. IDEXX Laboratories insiders own 1.0% of the company, currently worth about US$425m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
What Might The Insider Transactions At IDEXX Laboratories Tell Us?
It doesn't really mean much that no insider has traded IDEXX Laboratories shares in the last quarter. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the IDEXX Laboratories insiders selling. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of IDEXX Laboratories.
Of course IDEXX Laboratories may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here